Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
D000328:Adult; D001480:Basal Ganglia Diseases / Q000134:cerebrospinal fluid* / Q000188:drug therapy; D000242:Cyclic AMP / Q000134:cerebrospinal fluid*; D005260:Female; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid*; D006801:Humans; D006816:Huntington Disease / Q000134:cerebrospinal fluid; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D008297:Male; D010300:Parkinson Disease / Q000134:cerebrospinal fluid; D010648:Phenylacetates / Q000134:cerebrospinal fluid*; D011339:Probenecid / Q000134:cerebrospinal fluid / Q000627:therapeutic use*; D013577:Syndrome
D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D000242:Cyclic AMP; D011339:Probenecid; D006719:Homovanillic Acid